New Hope in MS Treatment
Release Date 2024-05-21 13:00
ResearchFrom the School of Medicine, our student Ege Anıl, Prof. Yasemin Gürsoy Özdemir, and colleagues published their research on the treatment of multiple sclerosis (MS), one of the leading causes of disability in young adults, in Frontiers in Cellular Neuroscience. Using a model called PLP-induced EAE to study potential treatments for multiple sclerosis (MS) disease progression, the team proposed a possible new therapeutic target by blocking a channel in pericyte cells with a molecule called Carbenoxolone (CBX) that reduces fibrosis.
https://www.frontiersin.org/articles/10.3389/fncel.2024.1403974/full
